UnitedHealth Group Incorporated (BMV:UNH)
Mexico · Delayed Price · Currency is MXN | Market Cap | 6.68T +39.4% |
| Revenue (ttm) | 7.87T +6.5% |
| Net Income | 246.76B -33.7% |
| EPS | 271.42 -32.8% |
| Shares Out | n/a |
| PE Ratio | 27.09 |
| Forward PE | 20.28 |
| Dividend | 160.21 (2.12%) |
| Ex-Dividend Date | Jun 15, 2026 |
| Volume | 498 |
| Open | 7,499.99 |
| Previous Close | 7,320.01 |
| Day's Range | 7,499.99 - 7,600.00 |
| 52-Week Range | 4,450.00 - 7,949.99 |
| Beta | 0.63 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and man... [Read more]
Financial Performance
In 2025, UnitedHealth Group's revenue was $447.57 billion, an increase of 11.81% compared to the previous year's $400.28 billion. Earnings were $12.06 billion, a decrease of -16.31%.
Financial numbers in USD Financial StatementsNews
UnitedHealth’s (UNH) Q2 Suggests the Worst May Be Over
The second-quarter results from UnitedHealth ($UNH) suggest the worst may finally be over for this healthcare company. UnitedHealth has been under pressure as rising operating costs squeezed profitabi...
UnitedHealth price target raised to $516 from $466 at JPMorgan
JPMorgan analyst Lisa Gill raised the firm’s price target on UnitedHealth (UNH) to $516 from $466 and keeps an Overweight rating on the shares. The firm updated the company’s model…
UnitedHealth price target raised to $493 from $470 at Mizuho
Mizuho raised the firm’s price target on UnitedHealth (UNH) to $493 from $470 and keeps an Outperform rating on the shares. The firm updated the company’s model post the Q2…
UnitedHealth price target raised to $526 from $485 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on UnitedHealth (UNH) to $526 from $485 and keeps an Overweight rating on the shares. The firm sees Q2 as…
UnitedHealth price target raised to $441 from $429 at Barclays
Barclays raised the firm’s price target on UnitedHealth (UNH) to $441 from $429 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q2…
Baird Upgrades UnitedHealth Stock (UNH) after Strong Q2 Earnings, But Remains Cautious.
UnitedHealth ($UNH) stock rose about 3% on Friday, as investors cheered the health insurer’s stellar Q2 earnings. Moreover, the company raised its full-year earnings outlook. Following the Q2 print, B...
UnitedHealth price target raised to $512 from $475 at BofA
BofA raised the firm’s price target on UnitedHealth (UNH) to $512 from $475 and keeps a Buy rating on the shares. UnitedHealth beat consensus by 31% and raised guidance by…
UnitedHealth price target raised to $500 from $480 at Truist
Truist analyst David MacDonald raised the firm’s price target on UnitedHealth (UNH) to $500 from $480 and keeps a Buy rating on the shares after the company reported “strong” Q2…
Morgan Stanley, KeyBanc Raise UNH Stock Price Targets after Strong Q2 Beat
UnitedHealth ($UNH) delivered a strong second-quarter earnings beat and raised its fiscal 2026 guidance. Following the results, analysts at KeyBanc and Morgan Stanley raised their price targets, while...
UnitedHealth price target raised to $478 from $463 at RBC Capital
RBC Capital raised the firm’s price target on UnitedHealth (UNH) to $478 from $463 and keeps an Outperform rating on the shares after its Q2 earnings beat and guidance raise.
UnitedHealth price target raised to $490 from $435 at Goldman Sachs
Goldman Sachs analyst Scott Fidel raised the firm’s price target on UnitedHealth (UNH) to $490 from $435 and keeps a Buy rating on the shares. The stock has outperformed the…
UnitedHealth price target raised to $500 from $420 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised the firm’s price target on UnitedHealth (UNH) to $500 from $420 and keeps an Outperform rating on the shares. The firm notes the company produced…
UnitedHealth price target raised to $490 from $460 at UBS
UBS analyst AJ Rice raised the firm’s price target on UnitedHealth (UNH) to $490 from $460 and keeps a Buy rating on the shares. The company is “making good progress…
UnitedHealth price target raised to $529 from $468 at Morgan Stanley
Morgan Stanley raised the firm’s price target on UnitedHealth (UNH) to $529 from $468 and keeps an Overweight rating on the shares. Q2 upside and higher 2026 targets “validate its…
UnitedHealth price target raised to $500 from $475 at KeyBanc
KeyBanc analyst Matthew Gillmor raised the firm’s price target on UnitedHealth (UNH) to $500 from $475 and keeps an Overweight rating on the shares. The firm notes the company’s Q2…
UnitedHealth's AI Bet Paid Off. Now It Is Selling the Playbook
Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal ov...
UnitedHealth Says AI Now Runs Every Function of Its Business
Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal ov...
UnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlook
Shares of UnitedHealth Group jumped to their highest level in more than a year Thursday after the health care and insurance giant announced results that handily topped Wall Street expectations.
UNH Rallies on Earnings, Question Marks in Health Insurers Remain
After shares were beaten down for most of the last year, UnitedHealth (UNH) posted an earnings beat and guidance impressive enough to ignite a rally in the legacy healthcare stock. Andy Wang points th...
Baird upgrades UnitedHealth to Neutral on earnings recovery
As previously reported, Baird analyst Michael Ha upgraded UnitedHealth (UNH) to Neutral from Underperform with a price target of $453, up from $287. Aggressive management actions and Medicare Advantag...
UnitedHealth upgraded to Neutral from Underperform at Baird
Baird analyst Michael Ha upgraded UnitedHealth (UNH) to Neutral from Underperform with a price target of $453, up from $287.
UnitedHealth Stock (UNH) Jumps as Big Q2 Beat and Higher 2026 Outlook Fuel Analyst Optimism
Health insurance provider UnitedHealth ($UNH) rose about 4% on Thursday after the company posted a strong Q2 earnings report and sharply raised its full‑year 2026 guidance. The company’s strong perfor...
UNH Taps 52-Week Highs Following Earnings Beat, Guidance Above Estimates
UnitedHealth (UNH) reached a 52-week high Thursday after the company posted a beat on earnings and set guidance above Wall Street expectations. Shares pulled back in the first hours of the trading ses...
Thursday's Morning Movers: UNH & JBHT Rally, UAL Falls After Earnings
It's all about earnings for Diane King Hall when it comes to Thursday's top stories. United Airlines (UAL) saw turbulence in its stock after beating, coming in part from expectations that the airliner...